DOJ strikes agreement with fourth generic drugmaker
Generic pharmaceutical company Apotex has agreed to pay a $24.1 million criminal fine for its role in a conspiracy to fix the price of a cholesterol medication as part of a deal to avoid prosecution by the Department of Justice.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10